s Administration Medical Center, Durham, NC, USA; 3Department of Neurology, Duke University, Durham, NC, USAAbstract: Parkinsonrsquo;s disease is a progressive neurodegenerative disease characterized by loss of nigral dopaminergic neurons associated with rigidity, resting tremor, bradykinesia, and ...
of Geriatrics, University Hospital, Linkoping, Sweden; 3Department of Neurology, 4Department of Pediatrics, Skaraborg Hospital, Skamp;ouml;vde, Sweden; 5Institution of Neurobiology, Karolinska Institutet, Stockholm, SwedenObjective: Nonmotor symptoms are common in Parkinsonamp;rsquo;s disease (PD). ...
parkinsonrsquo;s disease1 parkinsonrsquo;s disease affects the way you move. it happens when there is a problem with certain nerve cells in the brain. normally, these nerve cells make an important chemical called dopamine. dopamine sends signals to the part of your brain that controls movement...
Parkinson’s disease (PD) is a progressive neurological disease that causes both motor and nonmotor symptoms. While our understanding of putative mechanisms has advanced significantly, it remains challenging to verify biomarkers with sufficient evidence
Parkinson’s disease; diabetes; multimorbidity; mobility; executive function 1. Introduction Similar molecular pathways (e.g., inflammation, mitochondrial function, and metabolism) are dysregulated in both Parkinson’s disease (PD) and diabetes mellitus (DM) [1]. Individuals with type 2 DM may ...
Gene Therapy for Parkinson|[rsquo]|s Disease: Still a Hot Topic|[quest]|Neuropsychopharmacology, the official publication of the American College of Neuropsychopharmacology, publishing the highest quality original research and advancing our understanding of the brain and behavior.Jeffrey H Kordower...
’s Disease]]>doi:10.1111/j.1468-1331.2012.03697.xJellinger, K. ABlackwell Publishing LtdEuropean Journal of NeurologyEbmeier KP, O'Brien JT, Taylor J-P (eds). Psychiatry of Parkinson's Disease. Adv Biol Psychiatry. Basel, Karger, 2012, vol 27, pp 13-26....
Drug Watch: Epilepsy and Parkinson’s diseasedoi:http://formularyjournal.modernmedicine.com/node/141831Epilepsy and Parkinson’s diseaseMichele B. Kaufman, PharmDAdvanstar Communications Inc
The Mini-Mental Parkinson’s (MMP) as a cognitive screening tool in people with Parkinson’s disease. Curr Aging Sci. 2013;6:273–9.Caslake R, Summers F, McConachie D, et al. The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's disease[J]. ...
Parkinson's diseasepesticidessubstantia nigratoxic modelstransgenic models6-OHDAalphaAnimal models of Parkinson’s disease (PD) have been widely used in the past four decades to investigate the pathogenesis and pathophysiology of this neurodegenerative disorder. These models have been classically based on ...